A team of the New York Stem Cell Foundation (NYSCF) Research Institute have recently developed a new way to generate induced pluripotent stem (iPS) cell lines from human fibroblasts, acquired […]
Drs. Carrie Miceli and Stan Nelson at UCLA are developing an FDA approved drug that could boost the effectiveness of exon skipping drugs that are being developed and tested for Duchenne […]
Following the long awaited news of Sarepta’s phase IIB results for eteplirsen and continued Phase III progress of GSK/Prosensa’s drisapersen, as well as the recent developments with PTC Therapeutics and […]
CureDuchenne, a nonprofit organization that raises awareness and funds multiple research and development projects to cure Duchenne muscular dystrophy, announces the funding of three new research projects following its third […]